A study examined aspirin (ASA) hypersensitivity in a cardiology practice, reviewing medical records of over 11,000 patients from 2012 to 2013.
The prevalence of ASA hypersensitivity was found to be 1.88%, with skin reactions being the most common, and many patients misclassified based on symptoms like gastrointestinal issues.
The findings indicate a significant lack of proper documentation and management of ASA hypersensitivity, highlighting the need for better referral processes for desensitization and addressing unwarranted avoidance of ASA in affected patients.